Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 55/100

Failure Rate

22.2%

2 terminated/withdrawn out of 9 trials

Success Rate

60.0%

-26.5% vs industry average

Late-Stage Pipeline

22%

2 trials in Phase 3/4

Results Transparency

100%

3 of 3 completed trials have results

Key Signals

1 recruiting3 with results

Enrollment Performance

Analytics

N/A

3(60.0%)

Phase 4

2(40.0%)

5Total

N/A(3)

Phase 4(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (9)

Showing 9 of 9 trials

NCT05158751Not Yet Recruiting

Myocarditis Causing Premature Ventricular Contractions:Insights From the MAVERIC Registry

Role: collaborator

NCT05139329Not Yet Recruiting

The ORCHESTRATE-Myocarditis Registry

Role: collaborator

NCT05464511Not ApplicableNot Yet Recruiting

Impact of Steerable Delivery Sheaths on Successful Closure of LA A With AMULET

Role: collaborator

NCT05826665Recruiting

Observational Study to Examine the Procedural and Outcomes of AF Ablation Assisted by STAR Apollo™ Mapping System

Role: collaborator

NCT02781779Not ApplicableCompleted

Comparison of Outcomes Between the Use of Silverlon® Dressing and AQUACEL® AG Dressing Post Cardiac Device Implant

Role: lead

NCT03035227Phase 4Terminated

Catheter Ablation of Arrhythmias to Improve CRT Response

Role: lead

NCT02666742Phase 4Completed

DOACs for Stroke Prevention Post Ventricular Tachycardia Ablation

Role: lead

NCT04361838Not ApplicableTerminated

The COVID-19 ICU PRAYER Study

Role: lead

NCT01695564Completed

Safety and Efficacy of Left Atrial Appendage Occlusion Devices

Role: lead

All 9 trials loaded